Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon
I Can Extract Side Effects
Chapter 180

The Dragon Map Officially Appears

1,406 words 5 min read 2 views 4mo ago Source ​
Skip to the end of the chapter
Prev
Next

New Village City Eagle Country, a sunny weekend.

Xingesi opened a medical website he frequented, and a Toutiao immediately caught his eye.

"China's leading pharmaceutical company, Three Purities, claims to have developed Gene Drug for treating Menkes disease!"

"This drug uses the first-generation Gene Editing tool ZFN to successfully knock out the bonds on the mutated gene, thereby achieving the goal of completely curing the patient..."

Xingesi was stunned for a moment before he reacted. He read the news in one go, then rushed out of the study with great excitement and found his wife taking care of their daughter in the bedroom.

"Honey, guess what I found out? A China pharmaceutical company has developed Gene Drug that can cure Menkes disease! Our daughter can be saved!"

"God, do you know what you're saying?"

"I swear, it's all true. I saw on the news that this drug has started clinical trials in China, and there have been cases of patients being cured. Yes, they are using Gene Editing therapy, which can completely cure this damn disease."

"Oh, this is wonderful, it's a miracle! Contact the pharmaceutical company immediately, our daughter can't wait."

"Okay, I'll contact the pharmaceutical company right away. Wait for my good news."

Xingesi's daughter also suffered from Menkes Syndrome and was given a death sentence by doctors at a young age.

However, like most patients' families, they did not give up easily, but tried their best to save themselves.

Xingesi is no ordinary man. He is the founder of a well-known Wall Street hedge fund that manages more than $3 billion in assets. He was also a partner at Goldman Sachs, and his wife is a banker.

A year ago, the couple invested $10 million of their own money to establish a Charity Organization called the Menkes Foundation, with the wife serving as the foundation's chairperson, dedicated to funding research into the disease.

The foundation's goal is to find a treatment for the couple's daughter and 800 other children with Menkes as soon as possible, while there is still time.

The couple kept contacting established biopharmaceutical companies, hoping to provide a substantial research grant to interested companies to facilitate the development of a drug for Menkes.

However, even with such substantial financial resources and connections, things were still much more difficult than they had imagined.

At a biology conference, they invited the CEOs of seven pharmaceutical companies to dinner, but only two showed up.

Even the two executives who came were only there because of the two famous bankers; they had no intention of conducting research and development in this area.

It's no wonder these pharmaceutical companies aren't interested; the number of patients is simply too small. Even if they could raise tens of millions in charitable funds to conduct research, the potential sales of this drug would be far too small to recoup costs.

After much effort, Xingesi was almost in despair.

He later found that he couldn't persuade pharmaceutical companies, so he funded some university laboratories and invited experts in related fields to conduct research. However, by this time he had given up hope and was completely resigned to doing his best and leaving the rest to fate.

However, to their utter surprise, just when they were on the verge of giving up...

I was surprised to see a news report that a China pharmaceutical company is spontaneously researching drugs for Rare Disease, and has actually developed Gene Drug that can completely cure Menkes.

This was undoubtedly a piece of good news from heaven, and the two of them instantly erupted in intense emotions.

After a heated discussion, Xingesi contacted Sanqing Pharmaceutical on behalf of the foundation.

After a series of detailed inquiries, the existence of the Gene Drug was finally confirmed. The two were instantly overjoyed and hugged each other tightly, feeling the tremendous impact of the miracle.

Unfortunately, Three Purities's drug is still undergoing clinical trials and there is currently no clear timeline for its market launch, let alone its launch overseas.

This is no challenge for a high-profile individual like Xingesi, who possesses immense social influence.

He quickly expressed the foundation's strong interest and indicated his willingness to fully fund the overseas clinical trials of the drug.

Originally, according to Wei Kang, Menkes' Gene Drug would have cured most patients in China after completing clinical trials, so there was no strong motivation to immediately proceed with overseas Phase III clinical trials, given the high cost and long duration, and there was no need to rush it.

However, if there is a wealthy sponsor, that's a different story.

So they readily agreed to the wealthy family's request to conduct the Phase III clinical trial overseas.

With the support of the Menkes Foundation under Xingesi, Three Purities's overseas branch's application for Phase III clinical trial submitted to the FDA also proceeded smoothly.

In fact, the Eagle Country is very supportive of Rare Disease drugs, and provides policy incentives and fast-track application channels for companies that conduct research and development in this field, including a 7-year market exclusivity period, tax reductions and exemptions, and registration application fee reductions.

So not long after, under the foundation's financial offensive, overseas clinical trials for Menkes Syndrome began, and dozens of patients became the first lucky ones.

The Xingesi's daughter finally got to use the life-saving medicine she had been hoping for.

This is yet another touching overseas version of the story of "an elderly father who, having nowhere to find medicine, does everything in his power to save his daughter."

Of course, Wei Kang also seized this opportunity to promote the Longtu APP overseas.

Xingesi and other family members of children involved in the clinical trials downloaded and installed the English version from Apple and Google app stores.

After trying it out, Xingesi's eyes widened in surprise.

"Oh my God, this is more amazing and has more potential than Menkes' Gene Drug. Without a doubt, this is exactly what I imagine the Future Medicine to be like."

"Damn it, why are China companies always ahead of the curve, leaving Eagle Country companies far behind?"

"Unfortunately, Three Purities does not accept investment from Wall Street. However, I can completely replicate its business model by partnering with pharmaceutical companies in the Eagle Country. This will definitely be the best investment I have ever made in my life."

******

In China, with the successful progress of Menkes' clinical trials, 60 patients have received treatment and their conditions have been significantly alleviated. As long as they continue to receive injections every three months, they are expected to recover completely soon.

Three Purities Media, in collaboration with other media outlets, filmed the entire process, from Cao Yang's initial approach to the Gene Drug research and development process, all the way to the patients receiving treatment, into a documentary.

Survival of the fittest: The story of Gene Editing

The documentary became an instant hit online upon its release, receiving a high rating of 9.8 on major websites, making it comparable to "A Bite of China".

The Longtu APP also made a prominent appearance in the film, becoming a viral sensation across the internet along with the documentary.

Every viewer noticed the software's importance for patients with Rare Disease, and out of curiosity, they all downloaded it.

Although they don't need features like clinical trial applications and shared labs, electronic medical records are still very useful for most people.

Users can record their own health data. After a doctor's visit, they can take a picture of their test report and upload it to generate a complete data table, which will also provide evaluation and suggestions on their health status.

The forum also contains detailed medical information, which is an excellent resource for those seeking medical advice and treatment.

At least for them, it is a sufficiently authoritative medical forum, where they can quickly get satisfactory answers to questions about common ailments.

There's absolutely no need to worry about those alarming results from a simple Qiandu search that lead to Cancer as a primary cause of death.

This advertising campaign was very successful, and Dragon Map's app downloads skyrocketed instantly.

Three Purities officially announced the existence of the Longtu APP and spared no effort in promoting it to patients with Rare Disease across the entire network.

Wei Kang has great ambitions, and he also has enough strength to support those ambitions.

That is, to unite all Rare Disease across the country and make them a part of the medical big data system.

End of Chapter
Prev
NovelSummaries
Next

Explore the wiki

Wei Kang
Three Purities
China
Eagle Country

Comments

No comments yet.
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS